The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2015

Filed:

Nov. 25, 2013
Applicant:

Kyowa Hakko Kirin Co., Ltd, Tokyo, JP;

Inventors:

Munetoshi Ando, Tokyo, JP;

Hiroshi Ando, Tokyo, JP;

Mariko Nakano, Tokyo, JP;

Naoya Kameyama, Tokyo, JP;

Tsuguo Kubota, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); G01N 33/569 (2006.01); C12N 15/09 (2006.01); G01N 33/574 (2006.01); G01N 33/566 (2006.01); C12P 21/02 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56966 (2013.01); A61K 39/395 (2013.01); C07K 16/28 (2013.01); C12N 15/09 (2013.01); C12P 21/02 (2013.01); G01N 33/566 (2013.01); G01N 33/574 (2013.01); G01N 33/57407 (2013.01); G01N 33/57492 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/41 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present invention provides an anti-human FOLR1 antibody against diseases associated with human FOLR1-expressing cells, which specifically recognizes and binds to an amino acid sequence of human FOLR1 or a conformational structure thereof and also has a high effector activity such as antibody-dependent cellular cytotoxicity activity (ADCC activity). The present invention can provide a monoclonal antibody which specifically recognizes and binds to the amino acid sequence of human FOLR1 or the conformational structure thereof and also has ADCC activity and CDC activity, or an antibody fragment thereof, a DNA encoding the antibody, a vector comprising the DNA, a transformant obtained by introducing the vector, a method for producing the antibody or the antibody fragment thereof using the transformant, and a therapeutic agent and a diagnostic agent comprising the antibody or the antibody fragment as an active ingredient.


Find Patent Forward Citations

Loading…